American Marconi Wireless News - Stemtech Revolution 2026: A Bold New Era In Global Wellness

(Stemtech Corporation - OTC:STEK)

"Live Longer - Live Better - Live Younger"

John W. Meyer, President & COO of Stemtech says "we are redefining how wellness is understood, accessed, and sustained globally while improving people's quality of life. This is also in response to the growing demand for natural mobilization of stem cells - requiring this expansion."

At the beginning of 2026, Stemtech, the pioneer and global leader in stem cell nutrition, embarked on "Stemtech Revolution 2026", a transformative movement marking a bold new phase in the company's 20-year history of leadership in cellular wellness. This initiative reflects Stemtech's commitment to redefining preventive health and empowering individuals to optimize long-term vitality at the cellular level.

At the heart of this strategic shift is a multi-channel growth model designed to maximize reach, impact, and innovation:

1. The Stemtech Cellular Wellness Revolution

In 2026, Stemtech strengthened its focus on proactive, science backed cellular-level wellness. By emphasizing daily cellular vitality, Stemtech has built a framework for sustainable, lifelong wellness, amplified through the ongoing Stemtech Cellular Wellness Movement.

2. Hybrid Market Strategy

Stemtech successfully implemented a hybrid market model, operating both:

• MLM / Network Marketing Channel - supporting Independent Business Partners and fostering vibrant wellness communities.

  • https://www.stemtech.com/

• Stemtech BioSciences Direct-to-Consumer Retail Channel - expanding accessibility to consumers interested in nutritional wellness and quality of life improvements - the natural way and finding the benefits of stem cell nutrition.

  • https://stemtechbiosciences.com/

This dual-channel approach has broadened market reach and engagement while maintaining strong governance, protecting the MLM network, and preventing brand dilution. Early results demonstrate that retail initiatives have generated increased brand awareness and strengthened connections within the existing network.

3. Evolved Marketing and Branding Strategy

Stemtech's marketing ecosystem now blends premium science branding with character-driven engagement, creating a presence that is:

• Authoritative - grounded in science, credibility, and expertise

• Relatable - fun, engaging, and memorable

This strategy has differentiated Stemtech in the competitive nutraceutical landscape, building trust and community among consumers and partners alike.

The newly unveiled Stemtech Cellular Wellness Revolution 2026 logo symbolizes regeneration, scientific advancement, and a renewed commitment to longevity and human potential, while also recognizing Stemtech's history and signalling the beginning of a new era of growth and impact.

"This is more than a growth strategy - it's a global movement redefining how wellness is approached. Applied consistently across products, digital platforms, and educational content, Stemtech's multi-channel growth strategy is already laying the foundation for a recognizable global Cellular Wellness Movement, connecting consumers, Independent Business Partners, and wellness enthusiasts worldwide." - Sandra Kazickaite, VP Global Performance

ABOUT STEMTECH

Stemtech Corporation is a publicly traded wellness company specializing in stemceuticals^™ - all-natural, plant-based nutritional solutions designed to support the body's natural regenerative processes. Founded in 2018, following the acquisition of the operations from Stemtech International, Inc., (established in 2005), the company has a long history of innovation in stem cell nutrition and wellness science.

From 2010 through 2015, Stemtech International, Inc., was recognized four separate times on the Inc. 5000 Fastest-Growing Companies list. In 2018, Stemtech underwent an extensive executive reorganization, and continued operations under new leadership as Stemtech Corporation. In August 2021, Stemtech became a publicly traded company (STEK) and has expanded business opportunities for its Independent Business Partners (IBPs), who may earn incomes by sharing Stemtech products. Stemtech is well positioned as the pioneer in stem cell nutrition, oral, skin care and soon pet health products, to increase sales in the wellness industry.

Stemtech's comprehensive product portfolio reflects its dedication to optimal health. Our all-natural innovations like stemrelease3^™ (supports the body's natural regenerative signaling pathways), StemFlo^® Advanced (supports circulation and normal cellular communication and tissue support processes), MigraStem^® (supporting healthy aging and long-term vitality), and OraStem^® Toothpaste (whitening teeth, freshening breath, anti-microbial, promoting good gum health) demonstrate the company's unwavering commitment to quality-of-life products and natural effectiveness. The recent launch of Cellect One^® Shield: HOCL-a multipurpose mist for skin care, cleaning, and disinfecting-and its integration with the Cellect One^® Rapid Renew Stem Cell Peptide Night Cream (featuring the patented QXP ingredient) underscore Stemtech's innovative edge in the beauty, health and wellness industry.

Stemtech introduced StemPets^™ in June 2025 - a nutritional supplement designed for both dogs and cats. Tapping into the booming global pet wellness market, currently valued at over $303 billion annually, Stemtech is poised to transform pet health, with early adopters reporting remarkable improvements in health, energy, mood, and skin and hair quality for their four-legged furry family members.

For 20 years, Stemtech has not only championed the benefits of natural, plant-based ingredients but has also led the way in scientific innovation within the wellness, anti-aging and longevity sectors. As industry forecasts and studies from reputable sources like the Global Wellness Institute project unprecedented growth, Stemtech's unwavering commitment to quality and innovation ensures that they will remain at the forefront of this transformative journey-making everyone healthier, while slowing down the aging process naturally.

FORWARD LOOKING STATEMENTS

This announcement contains forward-looking statements within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, those identified by words such as "believes," "will," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in these forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, the results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, the impact of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future, changes in government policy and/or regulation, potential litigation by or against us, any governmental review of our products or practices, and other risks discussed from time to time in our filings with the Securities and Exchange Commission. We undertake no obligation to update any forward-looking statements, or any information contained in this press release or in other public disclosures, at any time. Finally, the investing public is reminded that only announcements or information about Stemtech Corporation disseminated by the Company and bearing its name are considered official.

For Investor Relations Information Contact:

CEO Charles S. Arnold
Email: [email protected]
Phone: +1 336-918-0507

Stemtech Corporation
Phone: +1 954-715-6000 ext 1040
Email: [email protected]

SOURCE: Stemtech Corporation

View the original press release on ACCESS Newswire

A.Mahlangu--AMWN